SIGNIFICANCE OF INSULIN-LIKE GROWTH FACTOR-I EXPRESSION IN BLADDER TUMORS

被引:0
作者
Ozbakir, Fikret [1 ]
Kaplan, Mustafa [1 ]
Usta, Ufuk [2 ]
Aktoz, Tevfik [1 ]
Atakan, Irfan Huseyin [1 ]
Inci, Osman [1 ]
机构
[1] Trakya Univ, Tip Fak, Urol Anabilim Dali, Edirne, Turkey
[2] Trakya Univ, Tip Fak, Patol Anabilim Dali, Edirne, Turkey
来源
TURKISH JOURNAL OF UROLOGY | 2008年 / 34卷 / 01期
关键词
Bladder tumor; Insulin-like growth factor-I; Recurrence;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Insulin-like growth factor-I is a mitogenic peptide which overexpression involved in the aberrant cell proliferation and malign transformation. It was thought that it can show the malign behavior of bladder tumors. Our aim in this study is to investigate the relationship between insulin like growth factor expression and tumor grade, stage and recurrence in patients with bladder tumor. Materials and Methods: 53 patients that performed transurethral tumor resection or radical cystectomy between 2002 and 2007 were included in this study. Insulin like growth factor-I staining was determined by immunohistochemically from the bladder tumor tissue. Then we investigated the relationship between insulin like growth factor expression in bladder tumor tissue and tumor grade, stage, and recurrence. Results: The mean age was 64.4+/-11.9, 32 patients have low grade, 21 have high grade; 35 have superficial, 18 have muscle invasive tumor. Of 35 patients with superficial tumors, 25 patients have regular follow-up and the mean follow-up duration was 21.9+/-8.1 month. There was no significant difference in insulin-like growth factor-I staining degree between low grade and high grade tumors. Insulin-like growth factor-I staining degree was same in both superficial and muscle invasive tumors. We found no relationship between recurrence and insulin-like growth factor-I staining degree. Conclusion: We found no association between tumor grade, stage, and recurrence and insulin-like growth factor-I staining degree in bladder tumors.
引用
收藏
页码:9 / 14
页数:6
相关论文
共 32 条
[1]   Serum insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in localized, metastasized prostate cancer and benign prostatic hyperplasia [J].
Aksoy, Y ;
Aksoy, H ;
Bakan, E ;
Atmaca, AF ;
Akçay, F .
UROLOGIA INTERNATIONALIS, 2004, 72 (01) :62-65
[2]   Preoperative plasma levels of interleukin-6 and its soluble receptor predict disease recurrence and survival of patients with bladder cancer [J].
Andrews, B ;
Shariat, SF ;
Kim, JH ;
Wheeler, TM ;
Slawin, KM ;
Lerner, SP .
JOURNAL OF UROLOGY, 2002, 167 (03) :1475-1481
[3]  
Beduk Y, 1998, TEMEL UROLOJI, P707
[4]   Role of nitric oxide and bcl-2 family genes in the regulation of human endometrial apoptosis [J].
Castro, A ;
Johnson, MC ;
Anido, M ;
Cortinez, A ;
Gabler, F ;
Vega, M .
FERTILITY AND STERILITY, 2002, 78 (03) :587-595
[5]   Plasma insulin-like growth factor I and prostate cancer risk: A prospective study [J].
Chan, JM ;
Stampfer, MJ ;
Giovannucci, E ;
Gann, PH ;
Ma, J ;
Wilkinson, P ;
Hennekens, CH ;
Pollak, M .
SCIENCE, 1998, 279 (5350) :563-566
[6]  
Decensi A, 2003, CLIN CANCER RES, V9, P4722
[7]  
Gohji K, 1996, CANCER, V78, P2379, DOI 10.1002/(SICI)1097-0142(19961201)78:11<2379::AID-CNCR17>3.0.CO
[8]  
2-Y
[9]   Cancer statistics, 2000 [J].
Greenlee, RT ;
Murray, T ;
Bolden, S ;
Wingo, PA .
CA-A CANCER JOURNAL FOR CLINICIANS, 2000, 50 (01) :7-33
[10]   Serum levels of insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-3, and prostate-specific antigen as predictors of clinical prostate cancer [J].
Harman, SM ;
Metter, EJ ;
Blackman, MR ;
Landis, PK ;
Carter, HB .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (11) :4258-4265